153
Views
3
CrossRef citations to date
0
Altmetric
Clinical Trial Report

Safety and Effectiveness of Lurasidone in Patients with Schizophrenia: A 12-Week, Open-Label Extension Study

ORCID Icon, , ORCID Icon, , , , , , ORCID Icon & show all
Pages 2683-2695 | Published online: 16 Aug 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Itaru Miura, Kei Watabe, Reiko Sakaguchi, Keisuke Okamoto & Hidenori Maruyama. (2022) Effectiveness of Lurasidone 80 mg in Patients with Schizophrenia: Results of an Open-Label, 12-Week Extension Study. Neuropsychiatric Disease and Treatment 18, pages 2627-2637.
Read now

Articles from other publishers (2)

María Elena Gamboa-Arancibia, Nelson Caro, Alexander Gamboa, Javier Octavio Morales, Jorge Enrique González Casanova, Diana Marcela Rojas Gómez & Sebastián Miranda-Rojas. (2023) Improving Lurasidone Hydrochloride’s Solubility and Stability by Higher-Order Complex Formation with Hydroxypropyl-β-cyclodextrin. Pharmaceutics 15:1, pages 232.
Crossref
A.V. Goryunov. (2021) Using Lurasidone in the treatment of mental illness in childhood. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 121:11, pages 77.
Crossref